SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-010476
Filing Date
2023-02-03
Accepted
2023-02-03 16:05:22
Documents
15
Period of Report
2023-01-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm235221d1_8k.htm   iXBRL 8-K 45159
2 EXHIBIT 3.1 tm235221d1_ex3-1.htm EX-3.1 6467
3 EXHIBIT 10.1 tm235221d1_ex10-1.htm EX-10.1 3416
  Complete submission text file 0001104659-23-010476.txt   263745

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230130.xsd EX-101.SCH 3033
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20230130_def.xml EX-101.DEF 26690
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230130_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230130_pre.xml EX-101.PRE 22595
9 EXTRACTED XBRL INSTANCE DOCUMENT tm235221d1_8k_htm.xml XML 3703
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 23585741
SIC: 2834 Pharmaceutical Preparations